Johnson & Johnson to Start Largest Ebola Vaccine Trial in Uganda After Congo Controversy
The government of Uganda announced Monday it has begun trial use for an experimental Ebola vaccine by Johnson & Johnson amid the second-worst Ebola outbreak on record. Uganda accepted the vaccine after the Democratic Republic of Congo (DRC)’s former health minister resigned over alleged pressure to introduce it into that country’s population.






































